Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
13 March 2012Website:
http://www.orgenesis.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Fri, 05 Jul 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
What type of business is Orgenesis?
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
What sector is Orgenesis in?
Orgenesis is in the Healthcare sector
What industry is Orgenesis in?
Orgenesis is in the Biotechnology industry
What country is Orgenesis from?
Orgenesis is headquartered in United States
When did Orgenesis go public?
Orgenesis initial public offering (IPO) was on 13 March 2012
What is Orgenesis website?
https://www.orgenesis.com
Is Orgenesis in the S&P 500?
No, Orgenesis is not included in the S&P 500 index
Is Orgenesis in the NASDAQ 100?
No, Orgenesis is not included in the NASDAQ 100 index
Is Orgenesis in the Dow Jones?
No, Orgenesis is not included in the Dow Jones index
When does Orgenesis report earnings?
The next expected earnings date for Orgenesis is 09 August 2024